Regulatory compliance – Page 39

ERES controls not implemented during system operation – risk-based ERES remediation

Remediation for ERES Control Failures During System Operation In the evolving landscape of pharmaceutical manufacturing, the implementation of effective electronic records and electronic signatures (ERES) controls is critical. When ERES…

Change impact not assessed during system upgrades – risk-based validation alignment

Assessing Change Impact During System Upgrades: A Playbook for GMP Compliance In the dynamic landscape of pharmaceutical manufacturing, system upgrades are pivotal yet often overlooked for their potential impact on…

Archival process non-compliant during internal audit – evidence package inspectors expect

Addressing Non-Compliance in Archival Processes: A Playbook for Effective Internal Audits As pharmaceutical organizations strive to adhere to stringent regulatory standards, issues related to archival process compliance can pose significant…

System access controls weak during system upgrade – inspection evidence requirements

Strengthening System Access Controls During Upgrades: An Inspection-Ready Playbook Pharmaceutical manufacturers frequently confront challenges when upgrading electronic systems. A particularly critical issue arises when system access controls are weak during…

Incomplete validation lifecycle during lifecycle management – CAPA and revalidation strategy

Managing Incomplete Validation Lifecycles in Pharmaceutical Operations Incomplete validation lifecycles can pose significant risks to pharmaceutical manufacturing operations, leading to potential regulatory non-compliance and gaps in product quality assurance. This…

ERES controls not implemented during inspection walkthrough – risk-based ERES remediation

Handling Incomplete ERES Controls During Inspection Walkthroughs: A Comprehensive Playbook The pharmaceutical industry is under increasing scrutiny for the management of Electronic Records and Electronic Signatures (ERES). When ERES controls…

Incomplete validation lifecycle during lifecycle management – preventing repeat validation findings

Preventing Repeated Validation Findings During Lifecycle Management The pharmaceutical manufacturing landscape increasingly faces challenges stemming from an incomplete validation lifecycle during lifecycle management. As regulatory scrutiny intensifies, organizations must address…

Hybrid paper-electronic workflows uncontrolled during inspection walkthrough – 21 CFR Part 11 compliance gaps

Managing Hybrid Paper-Electronic Workflows: Tactics for Compliance During Inspections The increasing integration of hybrid paper-electronic workflows has created new challenges in regulatory compliance. Specifically, 21 CFR Part 11 requirements for…

Validation gaps identified during system upgrades – CAPA and revalidation strategy

Strategies for Addressing Validation Gaps During System Upgrades In pharmaceutical manufacturing, modernization is necessary to remain competitive and compliant. However, system upgrades can often reveal validation gaps that pose significant…

Test article accountability issue during routine studies – inspection deficiency risk analysis

Managing Test Article Accountability During Routine Studies to Mitigate Inspection Deficiencies The integrity of test article accountability in routine studies is paramount in upholding Good Laboratory Practices (GLP) compliance. Even…

ERES controls not implemented during system operation – preventing repeat Part 11 findings

Implementing Effective Controls to Prevent ERES System Operation Failures The increasing reliance on electronic records and electronic signatures (ERES) in the pharmaceutical industry underscores the importance of robust controls. ERES…

Requalification overdue during inspection readiness – inspection evidence expectations

Addressing Requalification Gaps Ahead of Inspections: Evidence Expectations and Remediation Strategies The pharmaceutical manufacturing landscape requires strict adherence to regulatory guidelines, specifically during inspections where requalification of equipment and processes…